Tri-linyah Kit
Product Images NDC 16714-363

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tri-linyah (NDC 16714-363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Text panel titled 'Instructions for Administration of Tri-Linyah' outlining how to start use in women not currently using hormonal contraception with Day 1 or Sunday start options, including tablet color details. It includes guidance for switching from other contraceptive methods such as patches, vaginal rings, injections, intrauterine devices, and implants. It advises on use of additional non-hormonal contraception when starting Tri-Linyah and notes that complete counseling instructions are available in the FDA-Approved Patient Labeling.*

FDA Label Image

2 (Image 02)

A text panel titled 'Instructions for Missed Tri-Linyah Tablets' providing guidelines on what to do if one or two active tablets are missed during specific weeks, including timing to take missed and subsequent tablets. It also advises additional non-hormonal contraception use if sex occurs within 7 days after missing tablets. The panel details different instructions for missing tablets in Weeks 1, 2, or 3, and mentions starting a new pack under certain conditions.*

FDA Label Image

3 (Image 03)

Chemical structures of Norgestimate and Ethinyl Estradiol, the active ingredients in Tri-Linyah. The diagram shows the molecular frameworks including rings and functional groups for both compounds.*

FDA Label Image

4 (Image 04)

A data table titled 'Summary of norelgestromin, norgestrel and ethinyl estradiol pharmacokinetic parameters' presenting mean and standard deviation values for pharmacokinetic parameters of these analytes in Norgestimate/Ethinyl Estradiol tri-cyclic tablets across different cycles and days. Parameters include Cmax, tmax, AUC0-24h, and t½, with units and notes on abbreviations provided below the table.*

FDA Label Image

5 (Image 05)

Table summarizing acne vulgaris indications from two placebo-controlled trials comparing norgestimate and ethinyl estradiol tri-cycle tablets versus placebo. It displays the mean counts and percent reduction of inflammatory and non-inflammatory lesions at baseline and six months, plus differences in counts between treatment and placebo groups with confidence intervals.*

FDA Label Image

6 (Image 06)

Label showing the manufacturer information for Tri-Linyah, a kit containing Norgestimate and Ethinyl Estradiol. Manufactured for Northstar Rx LLC, Memphis, TN, and by Novast Laboratories Ltd., Nantong, China. Includes a toll-free contact number for Northstar Rx LLC.*

FDA Label Image

7 (Image 07)

A vertical infographic illustrating pregnancy rates per 100 women in one year related to various birth control methods. It ranks methods from 'fewer pregnancies' at the top, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal rings with hormones; to 'more pregnancies' at the bottom, listing no birth control. Intermediate methods include condoms, diaphragm, abstinence during fertile days, spermicide, and withdrawal.*

FDA Label Image

8 (Image 08)

Tri-Linyah kit includes a 28-tablet blister pack labeled with days of the week and colored pills in green, light blue, blue, and white. Directions indicate taking pills from left to right each week with color-coded weeks 1 to 4. Label includes dosage information and a monthly self-breast exam reminder. Labeled by Northstar Rx LLC.*

FDA Label Image

9 (Image 09)

Instructional diagram showing how to select and place a day label on a Tri-Linyah oral contraceptive kit. The image depicts a hand peeling a day label to align with the pill pack days of the week, with various pill colors and rows labeled as Green, Light Blue, Blue, and White for example purposes.*

FDA Label Image

10 (Image 10)

FDA Label Image

11 (Image 11)

The packaging label for Tri-Linyah, a prescription drug kit containing tablets with the active ingredients Norgestimate and Ethinyl Estradiol. The label details strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, and 0.25 mg/0.035 mg. It includes dosing information for a 28-day regimen, with the labeler identified as Northstar Rx LLC. The design features a prominent red flower graphic and multiple barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.